In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Patients hospitalized with community-acquired pneumonia are no better off when treated with prednisolone, according to trial results from The Netherlands. In fact, there’s…
A new study of physician practices finds that while many physicians are having difficulty communicating with patients because of language or cultural barriers, even fewer are following the…
Vincent A. DeLeo, MD, Chairman, Department of Dermatology, St. Luke’s-Roosevelt Hospital Center, New York, New York, and Beth Israel Medical Center, New York, discusses the US Food and…
NEW YORK (Reuters Health) – Oral anticoagulation might no longer be necessary after successful atrial fibrillation ablation, not even in patients at moderate-high risk for thromboembolism, a recent…
NEW YORK (Reuters Health) – Contrary to expectations, individual genetic markers don’t add up to a genetic risk score that’s any better than traditional risk factors for predicting…
NEW YORK (Reuters Health) – In selected patients with suspected early-stage gallbladder carcinoma, laparoscopy is a safe approach, Korean physicians report in the February Archives of Surgery. “Although…
NEW YORK (Reuters Health) – In treating acute coronary syndromes, a slow response to clopidogrel in the first hour of administration predicts a low response at 24 hours…
NEW YORK (Reuters Health) – While rates of childhood pneumonia have fallen in the U.S., the pediatric pneumonia that does occur is more often complicated by empyema, investigators…
NEW YORK (Reuters Health) – In patients with untreated advanced non-small-cell lung cancer (NSCLC), adding cetuximab (Erbitux) to platinum-based chemotherapy can improve overall survival and response rates, a…
NEW YORK (Reuters Health) – In chronic obstructive pulmonary disease (COPD), vertebral deformities often contribute to excess height loss with aging – which in turn may lead to…